The official further said the devotees requested the TTD to utilise the donation amount for the temple-run pilgrim free meal trust called S...

Modi made the remarks during his meeting with Indian COVID-19 vaccine manufacturers who said his leadership was a key factor in India being...

In May 2020, Modi had directed officials not to differentiate between the public and private sectors and said the government should work as...

Biological E, Dr Reddy’s Laboratories and Serum Institute of India are preparing to submit data for approval of their Covid-19 vaccines or ...

Krishna Ella, whose firm developed India's first indigenous vaccine for Covid-19, said 'pandemic vaccines and everything in future will com...

Welcoming the proposal for Rs 35,000 crore outlay for COVID-19 vaccines, city-based Bharat Biotech Chairman and Managing Director Krishna E...

The company had sought permission to conduct both phase-I and phase-II trials. “However, the SEC has asked the company to present data of p...

Bharat Biotech, which has developed India’s indigenous Covid-19 vaccine, Covaxin, has sought regulatory approval to start phase-1 and phase...

As the pandemic hit the world in 2020, Indian pharma industry rose to the occasion and was able to manufacture and maintain supply chains e...

How and if India decides to work with its large network of private hospitals on vaccine distribution could be crucial to any success in rei...

Covaxin, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology,...

This will be the second online conference that Bennett University will be organising in less than a week. At a time when leading research l...

“In our ongoing commitment to address the supply shortages of rabies vaccine, we are making additional investments to increase production c...

The Hyderabad-based construction firm, which underwent two major corporate restructuring exercises in the past few years, has sought more t...

The Telangana problem has eluded a solution for decades and has led to sometimes violent protests.

Glenmark has netted over $200 million in milestone and upfront payments while it has spent about $120-130 million on research.